ArticleBone marrow transplantation2021
Ruxolitinib-ECP combination treatment for refractory severe chronic graft-versus-host disease.
Kristina Maas-Bauer et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
30 papers cite it
this paperpooled ittrialcites it